Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Iovance Biotherapeutics (IOVA) over the last 5 years, with Q2 2025 value amounting to $334511.0.

  • Iovance Biotherapeutics' Shares Outstanding (Diluted Average) rose 1744.77% to $334511.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $334511.0, marking a year-over-year increase of 1744.77%. This contributed to the annual value of $289877.0 for FY2024, which is 2328.32% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Shares Outstanding (Diluted Average) of $334511.0 as of Q2 2025, which was up 1744.77% from $322868.0 recorded in Q1 2025.
  • In the past 5 years, Iovance Biotherapeutics' Shares Outstanding (Diluted Average) registered a high of $213.7 million during Q1 2023, and its lowest value of $224481.0 during Q2 2023.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $287347.0 (2024), whereas its average is $21.6 million.
  • The largest annual percentage gain for Iovance Biotherapeutics' Shares Outstanding (Diluted Average) in the last 5 years was 2687.8% (2024), contrasted with its biggest fall of 9987.54% (2024).
  • Quarter analysis of 3 years shows Iovance Biotherapeutics' Shares Outstanding (Diluted Average) stood at $235131.0 in 2023, then rose by 23.28% to $289877.0 in 2024, then grew by 15.4% to $334511.0 in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $334511.0 for Q2 2025, versus $322868.0 for Q1 2025 and $289877.0 for Q4 2024.